GR1002589B - Ενωσεις τριαρυλο ιμιδαζολης. - Google Patents

Ενωσεις τριαρυλο ιμιδαζολης.

Info

Publication number
GR1002589B
GR1002589B GR930100005A GR930100005A GR1002589B GR 1002589 B GR1002589 B GR 1002589B GR 930100005 A GR930100005 A GR 930100005A GR 930100005 A GR930100005 A GR 930100005A GR 1002589 B GR1002589 B GR 1002589B
Authority
GR
Greece
Prior art keywords
relates
mammal
formula
mediated diseases
aids
Prior art date
Application number
GR930100005A
Other languages
English (en)
Inventor
John Richard White
Timothy Francis Gallagher
John C. Lee
Jerry Leroy Adams
Original Assignee
Smithkline Beecham Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corporation filed Critical Smithkline Beecham Corporation
Publication of GR1002589B publication Critical patent/GR1002589B/el

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GR930100005A 1993-01-12 1993-01-12 Ενωσεις τριαρυλο ιμιδαζολης. GR1002589B (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GR93100005 1993-01-12

Publications (1)

Publication Number Publication Date
GR1002589B true GR1002589B (el) 1997-02-11

Family

ID=10941293

Family Applications (1)

Application Number Title Priority Date Filing Date
GR930100005A GR1002589B (el) 1993-01-12 1993-01-12 Ενωσεις τριαρυλο ιμιδαζολης.

Country Status (1)

Country Link
GR (1) GR1002589B (el)

Similar Documents

Publication Publication Date Title
CA2379445A1 (en) Lactams substituted by cyclic succinates as inhibitors of a.beta. protein production
CA2370206A1 (en) Pharmaceutical compositions for inhibition of cytokine production and secretion
MXPA05010958A (es) Derivados indazol como inhibidores jnk.
WO2003037271A3 (en) Compounds, pharmaceutical compositions and methods of use therefor
MY149577A (en) Cytokine inhibitors
CA2160928A1 (en) Compounds as pde iv and tnf inhibitors
TW515798B (en) Heterocyclic compounds for inhibition of gastric acid secretion, processes for their preparation and pharmaceutical compositions thereof
AU2003213806A1 (en) 1,4-disubstituted benzofused cycloalkyl urea compounds useful in treating cytokine mediated diseases
CA2127876A1 (en) Imidazole derivatives and their use as cytokine inhibitors
DE60014588D1 (en) Thioamidderivate
MD1838F2 (en) 5,6-dichlorbenzimidazole derivatives, process for obtaining thereof, pharmaceutical composition and method of treatment or prevention of herpetic viral infections
AP1408A (en) Phenyl yanthine derivatives.
CA2221114A1 (en) Atherosclerosis treatment
EP1072592A3 (en) 4-arylpiperidine derivatives for the treatment of pruritus
ATE411982T1 (de) Kondensierte verbindungen, die den vanilloid receptor subtype 1 (vr1)-rezeptor hemmen
NO965569L (no) Forbindelser og fremgangsmåter for behandling av kardiovaskulære, inflammatoriske og immunoforstyrrelser
EP1481968A3 (en) Cell adhesion-inhibiting anti-inflammatory and immune-suppressive compounds
AU4832401A (en) Use of pdgf receptor tyrosine kinase inhibitors for the treatment of diabetic nephropathy
DK192386A (da) Antistatisk hylde til elektronisk kredsloebskort
HU9201789D0 (en) Process for the production of substituted diamino-phtalimides and their analogues
AU2003294388A1 (en) 1, 2, 3- triazole amide derivatives as cytokine inhibitors
NO934372L (no) Nye forbindelser og farmasöytisk preparat derav
CA2099867A1 (en) 2-substituted-4,6-di-tertiary-butyl-5-hydroxy-1,3-pyrimidines useful as antiinflammatory agents
ES2110115T3 (es) Inhibidores de la agregacion de plaquetas.
NZ514696A (en) IL-8 receptor antagonists

Legal Events

Date Code Title Description
ML Lapse due to non-payment of fees